Secretory Autophagosomes from Alveolar Macrophages Exacerbate Acute Respiratory Distress Syndrome by Releasing IL-1β
Xinyi Xu,Xu Liu,Xuecheng Dong,Haibo Qiu,Yi Yang,Ling Liu
DOI: https://doi.org/10.2147/JIR.S344857
IF: 4.5
2022-01-07
Journal of Inflammation Research
Abstract:Xinyi Xu, Xu Liu, Xuecheng Dong, Haibo Qiu, Yi Yang, Ling Liu Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, People's Republic of China Correspondence: Yi Yang; Ling Liu Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, People's Republic of China Email ; Purpose: Activated alveolar macrophages (AMs) secrete extracellular vesicles and particles to mediate the inflammatory response in the acute respiratory distress syndrome (ARDS) although the underlying mechanisms are poorly understood. This study investigated whether secretory autophagosomes (SAPs) from AMs contribute to the inflammation-mediated lung injury of ARDS. Methods: We first isolated SAPs from cell culture supernatants of RAW264.7 cells and AMs and quantified Interleukin (IL)-1β levels in SAPs. Next, we employed a lipopolysaccharide (LPS)-induced ARDS model to investigate whether SAP-derived IL-1β could exacerbate lung injury. Finally, we used siRNA to knockdown Rab8a, both in vitro and in vivo, to investigate the effect of Rab8a on SAP secretion and lung injury in ARDS. Results: We found that AMs play an important role in ARDS by releasing a novel type of proinflammatory vesicles called SAPs that could exacerbate lung injury. SAPs are characterized as double-membrane vesicles (diameter ∼ 200 nm) with the expression of light chain 3 (LC3). IL-1β in SAPs is the key factor that contributes to the inflammation and lung injury in ARDS. We found that Rab8a is necessary for AMs to release SAPs with IL-1β, and Rab8a knockdown alleviated lung injury in ARDS. Conclusion: This study showed the novel finding that SAPs released from AMs play a vital role in ARDS by promoting an inflammatory response and the underlying mechanism was associated with IL-1β secretion. Keywords: secretory autophagosomes, alveolar macrophages, interlukin-1β, Rab8a, acute respiratory distress syndrome Acute respiratory distress syndrome (ARDS) occurs frequently in critically ill patients treated in the ICU with morbidity and mortality rates of ARDS 10.4% and more than 40%, respectively. 1 The pathogenesis of ARDS is mediated by the excessive inflammatory response of immune cells to various pulmonary or extrapulmonary factors. 2 Despite the high mortality rate, no effective treatment for the underlying pathogenesis of ARDS has been developed. Alveolar macrophages (AMs) constitute approximately 50% of the immune cells in the lungs and, through the synthesis and release of various inflammatory mediators, they play a pivotal role in the pathogenesis of ARDS. 3–5 Emerging evidence indicates that AMs autophagy could impact the pathogenesis or progression of ARDS. However, the role of macrophagic autophagy in ARDS appears to be complex, as it can be either cytoprotective or deleterious. 6,7 Autophagy is an evolutionarily conserved ubiquitous process for degrading and clearing subcellular components. 8,9 In contrast to degradative autophagy, secretory autophagy can bypass lysosome fusion and export various cytoplasmic substrates. 10–12 Recently, Bel et al reported that lysozyme-containing autophagosomes from Paneth cells secrete chemokines into the intestinal lumen to participate in the pathogenesis of Crohn's disease. 13 The autophagosomes released from cells are called secretory autophagosomes (SAPs) and are characterized as double-membrane vesicles (diameter ~200 nm) with the expression of light chain 3 (LC3). More recently, yeast, tumor cells, and endothelial cells were shown to release SAPs to amplify pathological signals and to transmit intercellular signals. 14–16 Thus, SAPs may participate in the regulation of the inflammatory response. Nonetheless, it is unknown whether AMs can release SAPs to modulate the inflammatory response in ARDS. Interleukin (IL)-1β is a well-known proinflammatory cytokine that is secreted by activated macrophages. In addition to conventional protein secretion by the endoplasmic reticulum (ER) and the Golgi apparatus, IL-1β can be secreted through several unconventional pathways. In recent years, several studies have shown that IL-1β secretion can be regulated via autophagy. 17,18 However, there is no evidence that IL-1β can be transported directly via intact SAPs. This study aimed to provide insight into the inflammatory regulation in ARDS and to identify potential drug targets for the treatment of ARDS. Therefore, we evaluated the role of AM-released SAPs in promoting the inflammatory response in ARDS and investigated wheth -Abstract Truncated-
immunology